Fulcrum Therapeutics (FULC) Leases (2022 - 2025)
Historic Leases for Fulcrum Therapeutics (FULC) over the last 4 years, with Q3 2025 value amounting to $4.6 million.
- Fulcrum Therapeutics' Leases fell 2340.64% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 2340.64%. This contributed to the annual value of $5.7 million for FY2024, which is 2079.15% down from last year.
- Per Fulcrum Therapeutics' latest filing, its Leases stood at $4.6 million for Q3 2025, which was down 2340.64% from $5.0 million recorded in Q2 2025.
- In the past 5 years, Fulcrum Therapeutics' Leases registered a high of $10.4 million during Q1 2022, and its lowest value of $4.6 million during Q3 2025.
- Its 4-year average for Leases is $7.3 million, with a median of $7.2 million in 2023.
- In the last 5 years, Fulcrum Therapeutics' Leases plummeted by 1717.37% in 2023 and then crashed by 2340.64% in 2025.
- Fulcrum Therapeutics' Leases (Quarter) stood at $9.1 million in 2022, then dropped by 20.82% to $7.2 million in 2023, then dropped by 20.79% to $5.7 million in 2024, then decreased by 18.82% to $4.6 million in 2025.
- Its Leases was $4.6 million in Q3 2025, compared to $5.0 million in Q2 2025 and $5.3 million in Q1 2025.